Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06298006

A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients

Uppföljning av Psykiatriska, Kognitiva Och Neurologiska Symtom Hos Post COVID-19 Patienter.

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
57 (actual)
Sponsor
Region Örebro County · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The prospective, longitudinal, open observational study monitors patients with cognitive and neuropsychological symptoms after COVID-19 infection, in a longitudinal manner to see how the disease has affected their physical, psychological and cognitive function, their ability to be active, return to work, their health-related quality of life in correlation with potential diagnostic and prognostic markers.

Detailed description

The aim is to increase knowledge of the underlying biological processes; how biomarkers correlate with degree of symptoms, mapping their role as diagnostic markers over time (24 months). The investigators follow up to 100 study participants with post-acute sequelae of SARS-CoV-2 infection (PASC) for 24 months, measure their physical, psychological and neurocognitive symtoms and how they change over time (three visits: baseline, 12 months, 24 months) in correlation with biomarkers in blood, cerebrospinal fluid and faeces samples as well as neuroradiological changes on MRI (baseline, 24 months). Knowledge about the late effects of COVID-19 and its pathogenesis is still unknown. The findings of the study can therefore be used as a guidance for future actions in healthcare and, in the best case, can lead to a possible, either curative or symptom-relieving, treatment.

Conditions

Interventions

TypeNameDescription
OTHERFollow-upFollow-up of neurocognitive and psychiatric symptoms in Post COVID patients (baseline, 12 months, 24 months) in correlation with biomarkers using MRI, fMRI, neuropsychological testing, lab samples (blood, CSF, microbiota).

Timeline

Start date
2022-02-22
Primary completion
2026-05-31
Completion
2027-06-30
First posted
2024-03-07
Last updated
2025-02-11

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06298006. Inclusion in this directory is not an endorsement.